Life Science Compliance Update

January

2016

January 2016: Life Science Compliance Update

Written by , Posted in January 2016 LSC Update, This Month in Compliance

The full text of this issue is now available to our subscribers. If you are a subscriber please log in now. You may also buy this issue by clicking on the button below.


   or   

October 2015 LSCU Cover

Issue Summary

The end of 2015 has been an extraordinary time for compliance with no shortage of issues for life sciences compliance professionals to deal with. This month’s issue covers stories about enforcement, data, pricing, free speech and transparency, in addition to the normal compliance operations topics. Below are the articles you will find in the January issue.


Issue Articles

Arrow

The Twenty-Year Ascendancy of Health Care Qui Tam Litigation in Five Simple Graphs
Kevin M. McGinty, Esq., Member, Health Care Enforcement Defense Practice,
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Abstract

Arrow

Specialty Pharma in the Spotlight – Novartis Settlement Finalized
Kaitlin Fallon, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

Got Compliance? – Recent DOJ Compliance Hire Expected to Make a Splash
Kaitlin Fallon, Esq., Staff Writer, Life Science Compliance Update
Abstract

Arrow

Gold Mining – The FCA and the Emergence of the Data-Driven Whistleblower
Robert N. Wilkey, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

Not to Say “I Told You So,” But… – Using Open Payments Data to Support Corporate Liability
Kaitlin Fallon, JD, Staff Writer for Life Science Compliance Update
Abstract

Arrow

Looking Backwards & Forwards – A 2015 Survey Roundup
Calisha D. Myers, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

Now You See It, Now You Don’t – A Review of CIA Provisions from 2009 to 2015
Calisha D. Myers, Esq., Staff Writer
Abstract

Arrow

Pricing -The New Compliance Frontier
Seth Whitelaw, JD, LLM, SJD, Editor and Kaitlin Fallon, Esq., Staff Writer for Life Science Compliance Update
Abstract

Arrow

When They Don’t Have Anything, They’ll Try Anything
James M. Beck, of counsel, Reed Smith LLP, Philadelphia, PA
Abstract

Arrow

The Purcell Uncertainty Principle – Ambiguity and Indirect Payments Under the Sunshine Act
Nicodemo (Nico) Fiorentino, Esq., Senior Advisor, Research & Compliance, for G&M Health LLC. and Editorial Board Member, Life Science Compliance Update
Abstract

Arrow

De-Polarizing Transparency
Ian J. Clark, Editorial Board Member, Life Science Compliance Update
Former Director of Transparency, Medical Affairs and Professional Education at Abbott Vascular
Abstract

Arrow

Global Transparency Trend: Lessons Learned from Sunshine shining on EFPIA
Lisa Keilty, Global VP of Compliance and Strategic Solutions, AHM
Abstract

Gravityscan Badge
Menu Title